Compare Albemarle Corp. (ALB) vs Cardinal Health Inc (CAH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Albemarle Corp. vs Cardinal Health Inc — how do they compare? Albemarle Corp. trades at $131.2 (market cap $15.27B), while Cardinal Health Inc trades at $240.13 (market cap $55.88B). The key difference: Cardinal Health Inc is far larger — about 3.7× Albemarle Corp.'s market cap, and Albemarle Corp. pays the higher dividend (1.27%). Which is the better fit depends on your goals.
| ALB | CAH | |
|---|---|---|
Market Cap | $15.27B | $55.88B |
Sector | Basic Materials | Health |
52-Week High | $215.62 | $240.26 |
52-Week Low | $72.58 | $146.04 |
Enterprise Value | $17.75B | $59.91B |
Dividend Yield | 1.27% | 0.86% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Albemarle Corp.
Albemarle is the world's largest lithium producer. Our outlook for robust lithium demand is predicated upon increased demand for electric vehicle batteries. Albemarle produces lithium from its salt brine deposits in Chile and the U.S. and its hard rock joint venture mines in Australia. Albemarle is also a global leader in the production of bromine, used in flame retardants. The company is also a major producer of oil refining catalysts.
Read more on ALB →About Cardinal Health Inc
Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Read more on CAH →
